Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project.

M Backhaus, S Ohrndorf, H Kellner, J Strunk, T M Backhaus, W Hartung, H Sattler, K Albrecht, J Kaufmann, K Becker, H Sörensen, L Meier, G R Burmester, W A Schmidt
{"title":"Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project.","authors":"M Backhaus,&nbsp;S Ohrndorf,&nbsp;H Kellner,&nbsp;J Strunk,&nbsp;T M Backhaus,&nbsp;W Hartung,&nbsp;H Sattler,&nbsp;K Albrecht,&nbsp;J Kaufmann,&nbsp;K Becker,&nbsp;H Sörensen,&nbsp;L Meier,&nbsp;G R Burmester,&nbsp;W A Schmidt","doi":"10.1002/art.24646","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To introduce a new standardized ultrasound score based on 7 joints of the clinically dominant hand and foot (German US7 score) implemented in daily rheumatologic practice.</p><p><strong>Methods: </strong>The ultrasound score included the following joints of the clinically dominant hand and foot: wrist, second and third metacarpophalangeal and proximal interphalangeal, and second and fifth metatarsophalangeal joints. Synovitis and synovial/tenosynovial vascularity were scored semiquantitatively (grade 0-3) by gray-scale (GS) and power Doppler (PD) ultrasound. Tenosynovitis and erosions were scored for presence. The scoring range was 0-27 for GS synovitis, 0-39 for PD synovitis, 0-7 for GS tenosynovitis, 0-21 for PD tenosynovitis, and 0-14 for erosions. Patients with arthritis were examined at baseline and after the start or change of disease-modifying antirheumatic drug (DMARD) and/or tumor necrosis factor alpha (TNFalpha) inhibitor therapy 3 and 6 months later. C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor, anti-cyclic citrullinated peptide, Disease Activity Score in 28 joints (DAS28), and radiographs of the hands and feet were performed.</p><p><strong>Results: </strong>One hundred twenty patients (76% women) with rheumatoid arthritis (91%) and psoriatic arthritis (9%) were enrolled. In 52 cases (43%), erosions were seen in radiography at baseline. Patients received DMARDs (41%), DMARDs plus TNFalpha inhibitors (41%), or TNFalpha inhibitor monotherapy (18%). At baseline, the mean DAS28 was 5.0 and the synovitis scores were 8.1 in GS ultrasound and 3.3 in PD ultrasound. After 6 months of therapy, the DAS28 significantly decreased to 3.6 (Delta = 1.4), and the GS and PD ultrasound scores significantly decreased to 5.5 (-32%) and 2.0 (-39%), respectively.</p><p><strong>Conclusion: </strong>The German US7 score is a viable tool for examining patients with arthritis in daily rheumatologic practice because it significantly reflects therapeutic response.</p>","PeriodicalId":8405,"journal":{"name":"Arthritis and rheumatism","volume":"61 9","pages":"1194-201"},"PeriodicalIF":0.0000,"publicationDate":"2009-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/art.24646","citationCount":"478","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthritis and rheumatism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/art.24646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 478

Abstract

Objective: To introduce a new standardized ultrasound score based on 7 joints of the clinically dominant hand and foot (German US7 score) implemented in daily rheumatologic practice.

Methods: The ultrasound score included the following joints of the clinically dominant hand and foot: wrist, second and third metacarpophalangeal and proximal interphalangeal, and second and fifth metatarsophalangeal joints. Synovitis and synovial/tenosynovial vascularity were scored semiquantitatively (grade 0-3) by gray-scale (GS) and power Doppler (PD) ultrasound. Tenosynovitis and erosions were scored for presence. The scoring range was 0-27 for GS synovitis, 0-39 for PD synovitis, 0-7 for GS tenosynovitis, 0-21 for PD tenosynovitis, and 0-14 for erosions. Patients with arthritis were examined at baseline and after the start or change of disease-modifying antirheumatic drug (DMARD) and/or tumor necrosis factor alpha (TNFalpha) inhibitor therapy 3 and 6 months later. C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor, anti-cyclic citrullinated peptide, Disease Activity Score in 28 joints (DAS28), and radiographs of the hands and feet were performed.

Results: One hundred twenty patients (76% women) with rheumatoid arthritis (91%) and psoriatic arthritis (9%) were enrolled. In 52 cases (43%), erosions were seen in radiography at baseline. Patients received DMARDs (41%), DMARDs plus TNFalpha inhibitors (41%), or TNFalpha inhibitor monotherapy (18%). At baseline, the mean DAS28 was 5.0 and the synovitis scores were 8.1 in GS ultrasound and 3.3 in PD ultrasound. After 6 months of therapy, the DAS28 significantly decreased to 3.6 (Delta = 1.4), and the GS and PD ultrasound scores significantly decreased to 5.5 (-32%) and 2.0 (-39%), respectively.

Conclusion: The German US7 score is a viable tool for examining patients with arthritis in daily rheumatologic practice because it significantly reflects therapeutic response.

评估一种新的7关节超声评分在日常风湿病实践:一个试点项目。
目的:介绍一种新的标准化的基于临床优势手和足7个关节的超声评分(德国US7评分)在日常风湿病实践中的应用。方法:超声评分包括临床优势手、足的以下关节:腕关节、第二、第三掌指关节和近端指间关节、第二、第五跖指关节。采用灰度(GS)和功率多普勒(PD)超声对滑膜炎和滑膜/腱鞘血管性进行半定量评分(0-3级)。对腱鞘炎和糜烂进行评分。GS滑膜炎评分范围为0-27,PD滑膜炎评分范围为0-39,GS腱鞘炎评分范围为0-7,PD腱鞘炎评分范围为0-21,糜烂评分范围为0-14。关节炎患者在基线和开始或改变疾病改善抗风湿药物(DMARD)和/或肿瘤坏死因子α (TNFalpha)抑制剂治疗3个月和6个月后进行检查。检查c反应蛋白水平、红细胞沉降率、类风湿因子、抗环瓜氨酸肽、28个关节疾病活动度评分(DAS28)和手脚x线片。结果:120例类风湿性关节炎(91%)和银屑病关节炎(9%)患者(76%)被纳入研究。在52例(43%)中,基线时的x线摄影显示糜烂。患者接受DMARDs(41%)、DMARDs联合TNFalpha抑制剂(41%)或TNFalpha抑制剂单药治疗(18%)。基线时,平均DAS28为5.0,GS超声评分为8.1,PD超声评分为3.3。治疗6个月后,DAS28评分显著降低至3.6 (Delta = 1.4), GS和PD超声评分分别显著降低至5.5(-32%)和2.0(-39%)。结论:德国US7评分是日常风湿病实践中检查关节炎患者的可行工具,因为它能显著反映治疗反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Arthritis and rheumatism
Arthritis and rheumatism 医学-风湿病学
自引率
0.00%
发文量
0
审稿时长
1 months
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信